Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Müschen

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Pathology|March 2, 2006
Immunoglobulin class-switch recombination occurs in mantle cell lymphomasW Klapper, M Szczepanowski, K Heidorn, et al.
The American Journal of Pathology|September 17, 1999
Involvement of soluble CD95 in Churg-Strauss syndromeM Müschen, U Warskulat, A Perniok, et al.
The Journal of Pathology|November 5, 1999
CD95 ligand expression in dedifferentiated breast cancerM Müschen, C Moers, U Warskulat, et al.
The Journal of Clinical Investigation|December 3, 1998
A critical role for transforming growth factor-beta in donor transfusion-induced allograft toleranceR Josien, P Douillard, C Guillot, et al.
Leukemia|September 15, 2017
Targeting the vulnerability to NAD<sup>+</sup> depletion in B-cell acute lymphoblastic leukemiaS Takao, W Chien, V Madan, et al.
Oncogene|June 4, 2013
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemiaE J Gang, Y-T Hsieh, J Pham, et al.
Leukemia|February 6, 2016
BCOR regulates myeloid cell proliferation and differentiationQ Cao, M D Gearhart, S Gery, et al.
Leukemia|February 6, 2016
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibitionS Köhrer, O Havranek, F Seyfried, et al.
Leukemia|August 31, 2016
Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activationA N McCracken, R J McMonigle, J Tessier, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Pathology|March 2, 2006
Immunoglobulin class-switch recombination occurs in mantle cell lymphomasW Klapper, M Szczepanowski, K Heidorn, et al.
The American Journal of Pathology|September 17, 1999
Involvement of soluble CD95 in Churg-Strauss syndromeM Müschen, U Warskulat, A Perniok, et al.
The Journal of Pathology|November 5, 1999
CD95 ligand expression in dedifferentiated breast cancerM Müschen, C Moers, U Warskulat, et al.
The Journal of Clinical Investigation|December 3, 1998
A critical role for transforming growth factor-beta in donor transfusion-induced allograft toleranceR Josien, P Douillard, C Guillot, et al.
Leukemia|September 15, 2017
Targeting the vulnerability to NAD<sup>+</sup> depletion in B-cell acute lymphoblastic leukemiaS Takao, W Chien, V Madan, et al.
Oncogene|June 4, 2013
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemiaE J Gang, Y-T Hsieh, J Pham, et al.
Leukemia|February 6, 2016
BCOR regulates myeloid cell proliferation and differentiationQ Cao, M D Gearhart, S Gery, et al.
Leukemia|February 6, 2016
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibitionS Köhrer, O Havranek, F Seyfried, et al.
Leukemia|August 31, 2016
Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activationA N McCracken, R J McMonigle, J Tessier, et al.
Pageof 3